Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 15, 2018

Total Value ($000): $179,342 (100.0% shares, 0.0% debt)

Holdings (32)

HANGER INC 13.9%
Value ($000) $24,988 Shares 1,199,602 Est. Cost $20.83 Unrealized
TELIGENT INC NEW 7.1%
Value ($000) $12,801 Shares 3,240,761 Est. Cost $3.39 Unrealized
ARENA PHARMACEUTICALS INC 6.3%
Value ($000) $11,231 Shares 244,050 Est. Cost $42.61 Unrealized
MGNX MACROGENICS INC 5.5%
Value ($000) $9,808 Shares 457,475 Est. Cost $19.75 Unrealized +7.9%
BMRN BIOMARIN PHARMACEUTICAL INC 5.2%
Value ($000) $9,351 Shares 96,428 Est. Cost $91.41 Unrealized +9.2%
PIERIS PHARMACEUTICALS INC 5.2%
Value ($000) $9,307 Shares 1,661,940 Est. Cost $5.76 Unrealized
ZBH ZIMMER BIOMET HLDGS INC 4.7%
Value ($000) $8,405 Shares 63,930 Est. Cost $111.94 Unrealized 0.0%
IOVA IOVANCE BIOTHERAPEUTICS INC 4.5%
Value ($000) $8,047 Shares 715,317 Est. Cost $12.52 Unrealized +13.4%
INTEC PHARMA LTD JERUSALEM 4.2%
Value ($000) $7,555 Shares 1,337,191 Est. Cost $4.60 Unrealized
REATA PHARMACEUTICALS INC 3.7%
Value ($000) $6,553 Shares 80,155 Est. Cost $25.04 Unrealized
CIGNA CORPORATION 3.4%
Value ($000) $6,088 Shares 29,236 Est. Cost $169.03 Unrealized
ALLERGAN PLC 3.3%
Value ($000) $5,981 Shares 31,400 Est. Cost $163.58 Unrealized
PROVIDENCE SVC CORP 3.2%
Value ($000) $5,733 Shares 85,217 Est. Cost $67.28 Unrealized
ALBIREO PHARMA INC 3.0%
Value ($000) $5,369 Shares 162,905 Est. Cost $32.96 Unrealized
VKTX VIKING THERAPEUTICS INC 2.7%
Value ($000) $4,780 Shares 274,410 Est. Cost $11.90 Unrealized 0.0%
SIERRA ONCOLOGY INC 2.6%
Value ($000) $4,624 Shares 2,720,089 Est. Cost $1.95 Unrealized
ASSEMBLY BIOSCIENCES INC 2.5%
Value ($000) $4,441 Shares 119,578 Est. Cost $38.27 Unrealized
KURA KURA ONCOLOGY INC 2.5%
Value ($000) $4,439 Shares 253,631 Est. Cost $16.94 Unrealized +13.2%
SHIRE PLC 2.4%
Value ($000) $4,242 Shares 23,400 Est. Cost $149.39 Unrealized
EIGER BIOPHARMACEUTICALS INC 2.3%
Value ($000) $4,097 Shares 341,457 Est. Cost $13.95 Unrealized
RETROPHIN INC 1.6%
Value ($000) $2,939 Shares 102,300 Est. Cost Unrealized
CNC CENTENE CORP DEL 1.6%
Value ($000) $2,878 Shares 19,875 Est. Cost $57.94 Unrealized +19.8%
AXGN AXOGEN INC 1.6%
Value ($000) $2,828 Shares 76,741 Est. Cost $43.65 Unrealized 0.0%
EOLS EVOLUS INC 1.4%
Value ($000) $2,578 Shares 138,460 Est. Cost $21.67 Unrealized 0.0%
CATALYST BIOSCIENCES INC 1.4%
Value ($000) $2,550 Shares 236,558 Est. Cost $10.78 Unrealized
STRONGBRIDGE BIOPHARMA PLC 1.1%
Value ($000) $2,056 Shares 423,846 Est. Cost $4.85 Unrealized
CIDARA THERAPEUTICS INC 0.8%
Value ($000) $1,430 Shares 324,902 Est. Cost $6.80 Unrealized
NOVELION THERAPEUTICS INC 0.7%
Value ($000) $1,314 Shares 444,068 Est. Cost $3.03 Unrealized
KEZAR LIFE SCIENCES INC 0.6%
Value ($000) $1,120 Shares 52,331 Est. Cost $18.13 Unrealized
OVASCIENCE INC 0.6%
Value ($000) $1,116 Shares 1,529,700 Est. Cost $0.73 Unrealized
MGTX MEIRAGTX HOLDINGS PLC 0.3%
Value ($000) $527 Shares 38,746 Est. Cost $10.80 Unrealized 0.0%
AQUINOX PHARMACEUTICALS INC 0.1%
Value ($000) $166 Shares 56,650 Est. Cost $2.65 Unrealized